Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
Accumulation of amyloid-β (Aβ) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of Aβ from the brain with age and Alzheimer's disease. A major pathway for elimination of Aβ and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of Aβ along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, Aβ rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E ε4 (ApoE4) mice. For drainage of Aβ to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of Aβ back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with Aβ in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/Aβ complexes to basement membrane laminin is significantly weaker than ApoE3/Aβ complexes. These results suggest that perivascular elimination of ApoE4/Aβ complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/Aβ/laminin interactions may increase the efficiency of elimination of Aβ in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
Faculty of Engineering and Environment, University of Southampton, UK. Electronic address: Jurgita.Zekonyte@port.ac.uk.
Jurgita
J
Zekonyte
Department of Neurology, Kanazawa University Hospital, Kanazawa, Japan.
Kenji
K
Sakai
Faculty of Medicine, University of Southampton, UK.
James A R
JA
Nicoll
Faculty of Medicine, University of Southampton, UK.
Roy O
RO
Weller
Faculty of Medicine, University of Southampton, UK.
Roxana O
RO
Carare
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D053318:Apolipoprotein E3 / Q000378:metabolism*; D053327:Apolipoprotein E4 / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D006801:Humans; D007797:Laminin / Q000378:metabolism*; D051379:Mice; D060066:Protein Interaction Maps
D016229:Amyloid beta-Peptides; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D007797:Laminin
Alzheimer's disease; Amyloid-β; Apolipoprotein E; Atomic force microscopy; Cerebral amyloid angiopathy; Laminin; Perivascular clearance pathways